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Abstract: This observational study aimed to develop novel nomograms that predict the benefits of
coronary angiography (CAG) after resuscitating patients with out-of-hospital cardiac arrest (OHCA)
regardless of the electrocardiography findings and to perform an external validation of these models.
Data were extracted from a prospective, multicenter registry of resuscitated patients with OHCA
(October 2015–June 2018). New nomograms were developed based on variables associated with
survival discharge and neurologic outcomes; their analysis included 723 and 709 patients, respectively.
Patient age (p < 0.001), prehospital defibrillation by emergency medical technicians (EMTs) (p = 0.003),
prehospital return of spontaneous circulation (ROSC) (p = 0.02), and time from collapse to ROSC
(p < 0.001) were associated with survival discharge. Patient age (p < 0.001), prehospital defibrillation
by EMTs (p < 0.001), and time from collapse to ROSC (p < 0.001) were associated with neurologic
outcomes. The new nomogram had a good predictive performance, with an area under the curve
(AUC) of 0.8832 (95% confidence interval (CI): 0.8358–0.9305) for survival discharge and an AUC
of 0.9048 (95% CI: 0.8627–0.9469) for neurologic outcomes. Novel nomograms that predict survival
discharge and good neurological outcomes after CAG in patients with OHCA were developed and
validated; they can be quickly and easily applied to identify patients who will benefit from CAG.
Keywords: nomograms; out-of-hospital cardiac arrest; coronary angiography; emergency medical
technicians; return of spontaneous circulation; emergency medical services; electrocardiography
1. Introduction
The management of out-of-hospital cardiac arrest (OHCA) remains a challenge world-
wide [1,2]. The current European Resuscitation Council and American Heart Association
guidelines recommend that all patients with cardiac arrest with a suspected cardiac cause
of arrest and ST-segment elevation on electrocardiography (ECG) undergo emergent coro-
nary angiography (CAG) [3,4]. In addition, these guidelines state that emergent CAG is
reasonable for some adult patients with OHCA and suspected cardiac origin who do not
have ST-segment elevation on ECG (such as those who are electrically or hemodynamically
unstable) [3,4].
Several previous observational studies and meta-analyses including patients with-
out ST-segment elevation on ECG reported a correlation between CAG and improved
neurological outcomes [5–7]. However, the Coronary Angiography after Cardiac Arrest
without ST Segment Elevation trial, conducted by Lemkes et al., reported no improvement
in the survival rates of patients resuscitated after OHCA with an initial shockable rhythm
in whom no ST segment elevation or signs of shock were present. Additionally, while
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coronary artery disease was found in 65% of patients who underwent CAG, most of whom
were in a stable state, only approximately 15% of the patients had acute unstable lesions,
and thrombotic occlusion was reported in only 5% of them [8]. Therefore, not all patients
who undergo successful resuscitation after cardiac arrest benefit from CAG.
The objective of this study was to develop novel nomograms that can predict the
prognosis of patients who undergo CAG regardless of the ECG findings after OHCA and
to perform an external validation of the novel nomograms. The nomograms developed in
this study provide a visual representation of a statistical predictive model that produces
numerical probabilities of clinical events, which is more exact than the conventional method
that uses odds ratios to predict prognosis [9].
2. Materials and Methods
2.1. Study Design and Setting
This observational study utilized data from a prospective, multicenter registry (Korean
Cardiac Arrest Research Consortium (KoCARC) registry) of patients with OHCA who were
resuscitated between October 2015 and June 2018. The patients received cardiopulmonary
resuscitation (CPR) in accordance with advanced cardiac life support recommendations;
targeted temperature management (TTM), extracorporeal CPR (E-CPR), CAG, and per-
cutaneous coronary intervention (PCI) were conducted according to each institution’s
protocol. The KoCARC is a multicenter, nationwide collaborative research network of
62 participating secondary or tertiary hospitals that was established to comprehend the
multitude of studies conducted in the field of OHCA and to reinforce the cooperative effort
in conducting these studies [10]. The KoCARC registry was designed to continuously
enroll patients with non-traumatic OHCA, who were transported to the emergency depart-
ments (EDs) of the participating hospitals. This study excluded patients with OHCA with
obvious non-cardiac etiologies, such as trauma, drowning, poisoning, burns, asphyxia,
or hanging. In addition, the registry excluded patients with OHCA who had terminal
illnesses documented by medical records, patients under hospice care, pregnant women,
and patients with pre-documented do-not-attempt-resuscitation cards [10]. This study was
approved by the Institutional Review Board of Yonsei University College of Medicine, Sev-
erance Hospital (no. 4-2015-1162) as well as the institutional review boards of each of the
participating hospitals. The KoCARC registry database was registered at clinicaltrials.gov
as protocol number NCT03222999.
2.2. Korean Emergency Medical Service (EMS) System
The Korean EMS system is a basic-to-intermediate level ambulance service operated by
16 provincial headquarters of the National Fire Department and a single-tiered, fire-based
EMS system [11]. The most qualified emergency medical technician (EMT) performs CPR
with an automated external defibrillator, evaluates the cardiac rhythm at scene, provides
advanced airway management, and administers intravenous fluids. EMTs are not allowed
to declare death or stop CPR on the scene unless the patient regains a pulse in the field
or during transport to an ED; therefore, all EMS-assessed patients are transported to the
nearest ED. In the case of prehospital EMS in Korea, E-CPR is not implemented [12].
2.3. Study Population
The KoCARC registry included data of 874 patients, who underwent CAG regardless
of ECG findings (both ST elevation and non-ST elevation) after the return of spontaneous
circulation (ROSC), registered from October 2015 to June 2018. In this study, patients aged
<18 years, those transferred from other hospitals after ROSC, and those with unknown
primary or secondary outcomes at hospital discharge were excluded. For time-related
variables (including the time required for emergency medical service (EMS) response),
values that were more than two standard deviations (SDs) from the mean were excluded
from the data analysis [13].
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2.4. Data Collection
All data of the KoCARC registry were anonymized and collected using a web-based
case report form (CRF) by the research coordinator at each institution. The CRF comprised
seven research fields classified with variables related to OHCA. Each field contained core
and optional variables. To improve data quality, the web-based data entry system filtered
out outliers or inaccurate values. The research coordinator of each participating hospital
was responsible for ensuring data accuracy. The research committee sought to improve the
quality of the data by regularly monitoring the data and providing continuous feedback
regarding inaccurate data [10].
The following data were retrieved from the KoCARC registry: patient demographics,
comorbidities (hypertension, diabetes mellitus, and dyslipidemia), prehospital character-
istics (witnessed arrest, place of arrest, bystander cardiopulmonary resuscitation [CPR],
prehospital defibrillation by bystanders or EMS personnel, primary ECG rhythm at the
scene, and epinephrine use by EMS providers), hospital characteristics (ROSC at ED arrival,
initial ECG rhythm at hospital, and total dose of epinephrine used at hospital), post-ROSC
characteristics (E-CPR, TTM, coronary angiographic finding, PCI, and vasopressor use in
the hospital), cardiac markers, and time intervals (time from EMS call to scene arrival, time
from collapse to ED arrival, time from collapse to ROSC, and time from ED arrival to CAG).
2.5. Outcome Measurements
The primary endpoint was survival at hospital discharge. The secondary outcome was
a favorable neurologic recovery at hospital discharge, defined as a cerebral performance
category (CPC) score of 1 or 2.
2.6. Statistical Analyses
All statistical analyses were performed using the R software, version 3.4.3 for Windows
(The R Foundation for Statistical Computing, Vienna, Austria). Continuous variables
are presented as means ± SDs, and categorical variables are presented as frequencies
(percentages). Independent two-sample t-tests were used to compare continuous variables,
and the chi-squared test or Fisher’s exact test was used to compare categorical variables,
as appropriate.
The study population was randomly allocated to either a training or validation set at
a 7:3 ratio using the split sample validation method. In the training set, a univariate logistic
regression analysis was performed to evaluate the prognostic ability of each variable for
the primary and secondary outcomes. Then, a multivariable logistic regression analysis
with variables with <20% missing data that had a p-value < 0.05 on the univariate binary
logistic regression was performed. The variables that were identified as independently
associated with survival or neurologic outcomes at hospital discharge were used to create
the novel nomograms using the training data set. The performances of the nomograms
were evaluated with respect to discrimination and calibration [14]. The predictive accura-
cies (discriminations) of the models were assessed using area under the receiver-operating
characteristic curve (AUC) values and 95% confidence intervals (CIs), which quantify the
level of concordance between the predicted probabilities and actual chance of the event
of interest occurring. The accuracy of the novel nomograms was internally validated
using the bootstrap method using resampling 1000 times of simple random sampling
with replacement. The calibration of the nomograms represents how accurate the pre-
dicted probabilities are compared with the observed outcome frequencies using graphic
representations (calibration curves). A curve along a 45-degree line indicates a perfect
calibration model in which the predicted probabilities are identical to the actual outcomes.
The calibration curves are presented as apparent and bias-corrected calibration plots using
the bootstrapping methods with 500 re-samples. The predictive accuracy and calibration
of the novel nomograms generated with the training set were subsequently tested in the
validation set. In addition, to verify whether our novel nomogram would be applicable
to the patients irrespective of the CAG findings, we performed the sensitivity analysis.
J. Clin. Med. 2021, 10, 3695 4 of 13
According to the CAG findings, the group was divided into patients without actual lesions
(normal coronary, insignificant lesion) and patients with actual lesions or decreased blood
flow (notable stenosis, vasospasm). All reported p-values are two-sided, and statistical
significance was set at p < 0.05.
3. Results
Within the study period, 7576 patients with OHCA were registered in the KoCARC
registry. Of these, 874 patients underwent CAG after ROSC. Patients who transferred
from other hospitals (n = 108), were aged <18 years (n = 1), or had missing data regarding
mortality (n = 17) or CPC score (n = 14) at hospital discharge and patients with data
outliers of time variables (n = 25) were excluded from the study. The final analyses
included 723 patients for the survival outcome group and 709 patients for the neurological
outcome group (Figure 1). Among the 723 patients in the survival outcome group, we
could confirm the CAG findings in 519 patients in the KoCARC registry: normal coronary
findings in 84 patients (16.2%), an insignificant lesion in 69 patients (13.3%), significant
stenosis in 303 patients (58.4%), and vasospasm in 63 patients (12.1%). Of the 723 patients
in the survival outcome group, 273 (168 survivors/105 deaths) underwent PCI. Among
the 709 patients in the neurological outcome group, we could confirm the CAG findings
in 508 patients: normal coronary, 83 patients (16.3%); insignificant lesion, 67 patients
(13.2%); significant stenosis, 296 patients (58.3%); and vasospasm, 62 patients (12.2%).
Among the 709 patients in the neurological outcome group, 268 (144 good neurologic
outcomes/124 poor neurologic outcomes) underwent PCI.
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The training set for the survival outcome analyses included 496 patients, and the vali-
dation set included 227 patients. The baseline characteristics are summarized in Table 1.
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Table 1. Patient demographics and clinical characteristics according to survival outcome at discharge.
Training Set (n = 496) Validation Set (n = 227)
Survival (n = 334) Death (n = 162) p-Value Survival (n = 141) Death (n = 86) p-Value
Age (years) 55.3 ± 13.0 64.3 ± 13.3 <0.001 56.1 ± 13.1 63.3 ± 13.8 <0.001
Sex, male 279 (83.5) 133 (82.1) 0.69 123 (87.2) 72 (83.7) 0.46
Medical history
Hypertension 122 (39.1) 80 (52.0) 0.008 64 (46.7) 39 (47.6) 0.9
Diabetes mellitus 65 (21.0) 55 (36.2) <0.001 24 (17.8) 29 (35.4) 0.003
Dyslipidemia 23 (7.80) 9 (6.2) 0.53 11 (8.6) 7 (9.6) 0.81
Bystander-witnessed 275 (84.1) 125 (77.2) 0.06 108 (77.1) 66 (76.7) 0.95
Place of arrest 0.02 0.09
Public 185 (44.8) 75 (46.9) 74 (53.6) 41 (47.6)
Private 122 (37.7) 76 (47.5) 60 (43.5) 36 (41.9)
Ambulance 16 (4.9) 9 (5.6) 4 (2.9) 9 (10.5)
Bystander CPR 0.008 0.1
Chest compressions 193 (61.3) 73 (46.8) 83 (62.4) 42 (50.0)
Prehospital defibrillation
by bystanders 14 (4.4) 1 (0.6) 0.03 6 (4.6) 1 (1.2) 0.18
Primary cardiac rhythm at
the scene <0.001 <0.001
Shockable 263 (85.1) 73 (46.5) 113 (85.0) 42 (51.9)
Prehospital defibrillation by
EMS providers 285 (85.6) 81 (51.3) <0.001 119 (85.6) 45 (52.3) <0.001
Epinephrine use by EMS
providers 24 (7.2) 21 (13.0) 0.04 16 (11.4) 15 (17.4) 0.2
Prehospital ROSC, yes 241 (72.2) 20 (12.4) <0.001 101 (71.6) 11 (12.8) <0.001
Primary cardiac rhythm at
hospital <0.001 0.27
Shockable 36 (45.6) 24 (17.52) 11 (35.5) 20 (28.7)
Full dose of epinephrine used
during CPR in the hospital
(mg)
1.6 ± 3.3 7.1 ± 6.6 <0.001 1.5± 2.9 5.7 ± 5.4 <0.001
SBP (mmHg) 129.0 ± 39.5 117.5 ± 40.8 0.07 133.2 ± 38.5 121.3 ± 41.7 0.17
DBP (mmHg) 82.4 ± 22.0 73.4 ± 28.1 0.02 83.5± 26.5 79.8 ± 32.4 0.55
HR (beats/min) 103.1 ± 30.6 98.2 ±32.0 0.32 100.2 ± 31.9 93.3 ± 34.1 0.34
Troponin I 74.4 ± 650.3 24.5 ± 141.9 0.42 32.4 ± 254.4 8.5 ± 26.7 0.45
E-CPR 18 (6.2) 48 (29.3) <0.001 6 (4.6) 20 (28.2) <0.001
Targeted temperature
management 132 (40.7) 52 (32.7) 0.17 44 (32.8) 28 (33.3) 0.61
PCI 99 (35.1) 66 (41.0) 0.22 43 (32.1) 30 (46.2) 0.05
Vasopressor use in the hospital 177 (54.3) 149 (92.0) <0.001 82 (60.3) 78 (91.8) <0.001
Time from EMS call to
scene arrival, min 7.1 ± 3.6 8.2 ± 3.6 0.002 7.9 ± 4.7 8.6 ± 5.3 0.33
Time from collapse to
ED arrival, min 30.3 ± 13.2 30.4 ± 15.2 0.93 31.3 ± 14.1 30.0 ± 13.0 0.51
Time from collapse
to ROSC, min 21.0 ± 14.1 44.3 ± 25.2 <0.001 21.9 ± 17.0 44.7 ± 24.0 <0.001
Time from ED arrival
to CAG, min 2042.5 ± 4903.8 204.6 ± 727.3 <0.001 1781.4± 5702.3 978.9 ± 5196.9 0.29
Variables are shown as means ± standard deviations or numbers (percentages). Abbreviations: CPR: cardiopulmonary resuscitation, EMS:
emergency medical service, ROSC: return of spontaneous circulation, SBP: systolic blood pressure, DBP: diastolic blood pressure, HR:
heart rate, E-CPR: extracorporeal cardiopulmonary resuscitation, PCI: percutaneous coronary intervention, ED: emergency department,
CAG: coronary angiography.
In the univariate logistic regression analysis, patient age, medical history, bystander
CPR, shockable rhythm at the scene, prehospital defibrillation by bystanders or EMS
providers, epinephrine use by EMS providers, prehospital ROSC, initial shockable rhythm
at hospital arrival, total dose of epinephrine used during CPR in the hospital, diastolic
blood pressure, vasopressor use in the hospital, and time-related variables (time from EMS
call to scene arrival, time from collapse to ROSC, and time from ED arrival to CAG) were
identified as significantly associated with survival discharge after CAG (Table 1). Among
them, patient age (p < 0.001), prehospital defibrillation by EMS providers (p = 0.003), pre-
hospital ROSC (p = 0.02), and time from collapse to ROSC (p < 0.001) were identified as
independent prognostic factors for survival discharge using multivariable logistic regres-
sion analysis (Table 2).
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Table 2. Predictors of survival discharge and good neurologic outcomes.
Survival Discharge Good Neurologic Outcomes
OR (95% CI) p-Value OR (95% CI) p-Value
Age 0.94 (0.90–0.98) <0.001 0.95 (0.92–0.98) <0.001
Prehospital defibrillation by EMS providers 3.52 (1.53–8.05) 0.003 7.84 (3.05–20.17) <0.001
Prehospital ROSC 2.96 (1.20–7.29) 0.02
Time from collapse to ROSC, min 0.95 (0.93–0.97) <0.001 0.91 (0.88–0.94) <0.001
Abbreviations: OR: odds radio, CI: confidence interval, EMS: emergency medical service, ROSC: return of spontaneous circulation.
These four prognostic factors were included in the novel nomogram for predicting
survival discharge after CAG. The time from collapse to ROSC (min) was the factor that
contributed the most to the prediction of survival discharge after performing CAG, fol-
lowed by patient age (Figure 2a). The total points of the variables in the nomogram allowed
for the prediction of the survival discharge probability of the patients in the CAG group.
For example, a 65-year-old (25 points) patient who was defibrillated by EMS providers
(20 points) with ROSC before hospital arrival (17.5 points) and a time from collapse to
ROSC of 10 min (92.5 points) would have a total score of 155 and a predicted probability of
survival discharge of approximately 90%. The discriminative ability of the novel nomo-
gram was good, with an AUC of 0.8832 (95% CI: 0.8358–0.9305). The AUC of the internally
validated nomogram was 0.8881 (95% CI: 0.8386–0.9339), with a statistical power similar
to that of the initial nomogram. In the validation set, the discrimination was excellent,
with an AUC of 0.9002 (95% CI: 0.869–0.9315) (Figure 2b). The calibration plot of the
nomogram demonstrated an excellent agreement between the predicted and observed
probabilities of survival discharge in both sets (Figure 2c). The sensitivity analysis in pa-
tients with or without actual lesions showed that the AUC values of the novel nomogram
were 0.8557 (95% CI: 0.7832–0.9281) and 0.9439 (95% CI: 0.8824–0.9999), which were not
significantly different from that of the initial nomogram (p = 0.53 and p = 0.13, respectively).
The training set for the neurologic outcome analyses included 489 patients, and the
validation set included 220 patients. The baseline characteristics and variables found to
be associated with favorable neurologic outcomes are summarized in Table 3. Patient age
(p < 0.001), prehospital defibrillation by EMS providers (p < 0.001), and time from collapse
to ROSC (p < 0.001) were identified as independent prognostic factors for neurologic
outcomes (Table 2).
These three prognostic factors were included in the novel nomogram for predicting
neurologic outcomes at hospital discharge. The time from collapse to ROSC was the most
contributing factor in this nomogram (Figure 3a). The AUC of the nomogram was 0.9048
(95% CI: 0.8627–0.9469), and the internally validated AUC was 0.9070 (95% CI: 0.8554–0.9509).
In the validation set, the discrimination of the nomogram was good, with an AUC of 0.8742
(95% CI: 0.8383–0.9101) (Figure 3b). The calibration plot of the nomogram demonstrated a
good agreement in both sets (Figure 3c). The sensitivity analysis in patients with or without
actual lesions showed that the AUC values of the novel nomogram were 0.8906 (95% CI:
0.8234–0.9579) and 0.9490 (95% CI: 0.8872–0.9999), which were not significantly different to
that of the initial nomogram (p = 0.73 and p = 0.25, respectively).
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The training set for the neurologic outcome analyses included 489 patients, and the 
validation set included 220 patients. The baseline characteristics and variables found to be 
associated with favorable neurologic outcomes are summarized in Table 3. Patient age (p 
< 0.001), prehospital defibrillation by EMS providers (p < 0.001), and time from collapse to 
ROSC (p < 0.001) were identified as independent prognostic factors for neurologic out-
comes (Table 2).  
Table 3. Patient demographics and clinical characteristics according to neurologic outcomes at discharge. 
Variables 
Training Set (n = 489)  Validation Set (n = 220)  
Good Neurologic 
Outcome (CPC 1, 2) 
(n = 210) 
Poor Neurologic 
Outcome (CPC ≥ 
3) (n = 279) 
p-Value 
Good Neurologic 
Outcome (CPC 1, 2) 
(n = 105) 
Poor Neurologic 
Outcome (CPC ≥ 3) 
(n = 115) 
p-Value 
Age (years) 54.6 ± 12.7  63.0 ± 13.6 <0.001 55.0 ± 12.8 62.7 ± 13.5 <0.001 
Sex, male 234 (83.9) 170 (80.9) 0.4 100 (86.9) 90 (85.7) 0.79 
Medical history       
Hypertension 101 (38.4) 99 (50.3) 0.01 52 (46.9) 47 (46.1) 0.91 
Diabetes mellitus 47 (18.1) 71 (36.4) <0.001 17 (15.6) 35 (34.7) 0.001 
Dyslipidemia 22 (8.76) 10 (5.41) 0.18 11 (10.7) 7 (7.5) 0.45 
Bystander-witnessed 232 (84.7) 162 (77.9) 0.06 87 (76.3) 82 (78.1) 0.75 
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Private 103 (37.9) 89 (43.2)  51 (45.5) 41 (39.1)  
Ambulance 12 (4.4) 13 (6.3)  3 (2.7) 10 (9.5)  
Bystander CPR    <0.001   0.01 
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  <0.001   <0.001 
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Prehospital defibrillation by 
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Figure 2. Nomogram for predicting survi al discharge. (a) The novel nomogram for predicting survival discharge developed
using the training data set is shown. (b) The discriminative ability of the nomogram is excellent, with an area under the
curve of 0.9002 (95% confidence interval: 0.869–0.9315). (c) The calibration plot of the prediction model indicates good
agreement between the predicted and observed probabilities of survival discharge. Abbreviations: EMS: emergency medical
service, ROSC: return of spontaneous circulation.
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Table 3. Patient demographics and clinical characteristics according to neurologic outcomes at discharge.
Variables
Training Set (n = 489) Validation Set (n = 220)
Good Neurologic
Outcome (CPC 1, 2)
(n = 210)
Poor Neurologic




Outcome (CPC 1, 2)
(n = 105)
Poor Neurologic
Outcome (CPC ≥ 3)
(n = 115)
p-Value
Age (years) 54.6 ± 12.7 63.0 ± 13.6 <0.001 55.0 ± 12.8 62.7 ± 13.5 <0.001
Sex, male 234 (83.9) 170 (80.9) 0.4 100 (86.9) 90 (85.7) 0.79
Medical history
Hypertension 101 (38.4) 99 (50.3) 0.01 52 (46.9) 47 (46.1) 0.91
Diabetes mellitus 47 (18.1) 71 (36.4) <0.001 17 (15.6) 35 (34.7) 0.001
Dyslipidemia 22 (8.76) 10 (5.41) 0.18 11 (10.7) 7 (7.5) 0.45
Bystander-witnessed 232 (84.7) 162 (77.9) 0.06 87 (76.3) 82 (78.1) 0.75
Place of arrest 0.02 0.003
Public 157 (57.7) 104 (50.5) 58 (51.8) 54 (51.5)
Private 103 (37.9) 89 (43.2) 51 (45.5) 41 (39.1)
Ambulance 12 (4.4) 13 (6.3) 3 (2.7) 10 (9.5)
Bystander CPR <0.001 0.01
Chest compression 174 (65.4) 91 (45.5) 73 (66.4) 50 (49.5)
Prehospital defibrillation
by bystanders 13 (4.9) 2 (1.0) 0.02 5 (4.6) 2 (2.0) 0.31
Primary cardiac rhythm
at the scene <0.001 <0.001
Shockable 233 (90.3) 99 (48.7) 100 (92.6) 53 (53.00)
Prehospital defibrillation
by EMS providers 250 (89.9) 111 (53.6) <0.001 103 (91.2) 58 (55.2) <0.001
Epinephrine use by
EMS providers 16 (5.7) 29 (13.8) 0.002 12 (10.4) 18 (17.1) 0.15
Prehospital ROSC, yes 226 (81.0) 34 (16.2) <0.001 93 (80.9) 18 (17.1) <0.001
Primary cardiac rhythm
at hospital <0.001 0.005
Shockable 23 (53.5) 37 (21.9) 10 (71.4) 20 (24.1)
Full dose of epinephrine
used during CPR in the
hospital (mg)
1.0 ± 2.8 6.2 ± 6.1 <0.001 1.2 ± 2.9 5.0 ± 5.2 <0.001
SBP (mmHg) 129.4 ± 36.4 122.0 ± 44.8 0.19 133.7 ± 39.3 122.9 ± 41.1 0.2
DBP (mmHg) 83.7± 20.5 74.7 ± 27.8 0.01 85.2 ± 27.9 78.6 ± 29.1 0.28
HR (beats/min) 101.8 ± 28.7 102.6 ± 34.1 0.86 99.3 ± 29.7 95.7 ± 35.7 0.61
Troponin I 85.8 ± 705.6 21.6 ± 127.6 0.28 39.8 ± 283.6 7.4 ± 24.4 0.31
E-CPR 9 (3.9) 55 (26.1) <0.001 3 (2.7) 22 (25.0) <0.001
Targeted temperature
management 103 (38.0) 82 (40.0) 0.63 37 (33.6) 34 (33.3) 0.96
PCI 85 (36.8) 76 (36.9) 0.98 35 (30.4) 38 (45.8) 0.03
Vasopressor use
in the hospital 137 (50.4) 184 (88.0) <0.001 59 (53.6) 95 (90.5) <0.001
Time from EMS call to
scene arrival, min 6.9 ± 3.3 8.1 ± 3.9 <0.001 7.6 ± 4.9 8.8 ± 5.0 0.08
Time from collapse to ED
arrival, min 30.2 ± 13.4 30.5 ± 14.7 0.84 30.9 ± 14.3 30.7 ± 13.3 0.91
Time from collapse to
ROSC, min 18.3 ± 11.7 42.0 ± 24.1 <0.001 19.6 ± 16.5 42.6 ± 22.9 <0.001
Time from ED arrival to
CAG, min 2184.0 ± 4916.1 483.7 ± 2535.2 <0.001 2218.1 ± 6287.7 828.4 ± 4676.9 0.07
Variables are shown as means ± standard deviations or numbers (percentages). Abbreviations: CPC: cerebral performance category,
CPR: cardiopulmonary resuscitation, EMS: emergency medical service, ROSC: return of spontaneous circulation, SBP: systolic blood
pressure, DBP: diastolic blood pressure, HR: heart rate, E-CPR: extracorporeal cardiopulmonary resuscitation, PCI: percutaneous coronary
intervention, ED: emergency department, CAG: coronary angiography.
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4. Discussion
In this study, novel nomograms that predict survival discharge and good neurological
outcomes for performing CAG in patients with OHCA were developed and validated. To
the best of our knowledge, this is the first study to create a nomogram that determines if
CAG will be beneficial by considering various variables in patients with OHCA. These
no ogra s were based on patient age, prehospital ROSC, prehospital defibrillation by
E S providers, and ti e from collapse to ROSC, which are readily available data at
the prehospital and in-hospital stages of treatment. Therefore, they can be used in an
emergency situation and easily applied to each patient individually.
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The time from collapse to ROSC was the most contributing variable in the nomograms
predicting survival discharge and good neurologic outcomes at hospital discharge after
CAG in patients with OHCA. The time from collapse to ROSC may be associated with
ischemia. Cardiac ischemia and adenosine triphosphate depletion are believed to worsen
over time after cardiac arrest [15]. Longer ischemic periods result in worsened neurologi-
cal prognoses, and ultimately, increased probabilities of death. Therefore, the time from
collapse to ROSC affects the severity of hypoxic-ischemic brain injuries and is one of the
major causes of death after cardiac arrest [16,17]. Thus, the time from collapse to ROSC
is an important factor for determining the benefits of CAG. Patient age and prehospital
defibrillation by EMS providers are also common variables to both nomograms. Several
previous studies have reported that a younger age and the use of automated external defib-
rillators at the scene are associated with better outcomes for patients with OHCA [18–20].
Patient age has more influence on the survival discharge in this study. Prehospital ROSC
was included on the survival discharge nomogram and not on the neurologic outcome
nomogram. A study conducted by David et al. reported that cardiac arrest survival is
rare without prehospital ROSC [21]. Another study reported that patients with an initial
shockable rhythm or EMS-witnessed arrest in the absence of field ROSC had a survival
rate of 0.5% [22]. The results of these previous studies support the nomograms developed
in this study.
Recent studies have reported that performing CAG early improved the neurological
outcomes and survival rate regardless of ECG findings in survivors of OHCA [23,24]. One
study showed that early CAG may be associated with improved survival in patients with
bystander-witnessed OHCA with shockable rhythms [25]. However, other studies have re-
ported no association between early CAG and survival in patients with non-ST elevation af-
ter cardiac arrest [26,27]. In this study, the time from ED arrival to CAG was approximately
10 times longer in the survival group than in the deceased group (2042.5 ± 4903.8 min
vs. 204.6 ± 727.3 min; p < 0.001) and approximately five times longer in the good neu-
rologic outcome group than in the poor neurologic outcome group (2184.0 ± 4916.1 min
vs. 483.7 ± 2535.2 min; p < 0.001). These results should not be interpreted to mean that
delayed or late CAG results in better outcomes than early CAG. Rather, these results may
be attributed to the fact that severely ill patients often receive early CAG, resulting in
decreased survival rates and poor neurological outcomes among patients who receive
early CAG. In contrast, hemodynamically stable patients who have regained consciousness
may receive delayed CAG. The results of previous studies combined with those of this
study indicate that it is difficult to decide whether to perform CAG simply based on time
because of the various clinical situations that act as confounding factors. Therefore, the
novel nomogram developed in this study is a good alternative for deciding whether or not
to perform CAG.
This study is not without limitations. First, despite the constant efforts of the KoCARC
registry committee to improve the reliability and accuracy of the data, some patients
had inaccurate or missing data, which could not be included in this study. Second, only
data regarding survival and neurologic prognoses at the time of hospital discharge were
collected, although long-term data were not collected in this study. Third, some outlier
data for time-related variables were excluded to increase the reliability of the study. Fourth,
this study did not include the data of some variables such as echocardiographic finding,
which was important to identify clinically relevant characteristics of the patients. Fifth, in
the case of patients who underwent E-CPR, different results were obtained, but the analysis
was not conducted owing to the small number of patients who underwent E-CPR in this
study. Finally, data regarding ST segment elevation on the initial ECG were not available
in the KoCARC registry. For the practical application of the newly developed nomogram,
further validations including patients with suspected cardiac causes of arrest and non-ST
segment elevation are needed.
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5. Conclusions
Novel nomograms that predict survival discharge and good neurological outcomes of
patients with OHCA undergoing CAG were developed and validated in this study. These
nomograms use data that can be obtained during the prehospital and hospital resuscitation
period and can be quickly and easily applied to decide if CAG should be performed in
resuscitated patients with OHCA.
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